Dark

Check out our API

AWKNF
AWAKN LIFE SCIENCES CORP
stock OTC

Inactive

Dec 13, 2024

0.0650USD-18.444%(-0.0147)45,401

Pre-market

0.00USD-100.000%(-0.08)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 18, 2022

07:39AM EST Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS Benzinga

Jan 11, 2022

03:28PM EST Ketamine Therapy Shows Potential In Treatment Of Alcohol Use Disorder, New Study Finds Benzinga

Nov 1, 2021

12:39PM EDT Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation Benzinga

Oct 26, 2021

01:49PM EDT Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent Benzinga

Oct 18, 2021

01:37PM EDT Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation Benzinga

08:36AM EDT KCSA Psychedelics Virtual Investor Conference Presentations Available for PR Newswire

Oct 13, 2021

04:25PM EDT There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are Benzinga

Oct 11, 2021

08:20AM EDT KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th PR Newswire

Sep 27, 2021

09:19AM EDT Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study Benzinga

Sep 22, 2021

11:51AM EDT Is Ketamine A Psychedelic? Depends On Who You Ask Benzinga

Sep 20, 2021

12:51PM EDT Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial Benzinga

Aug 30, 2021

11:21AM EDT Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold Benzinga

Aug 24, 2021

05:14PM EDT Can Ketamine Be Used To Treat Gambling Addiction? Awakn Life Sciences Wants To Find Out Benzinga

Aug 16, 2021

08:42AM EDT Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M Benzinga

Jul 28, 2021

05:26PM EDT UK Psychedelics Co. Awakn Life Sciences Begins Listing On OTC Markets Benzinga

Share